DAratumumab and REvlimid REfractory MM

Clinical trial NCT06541860 · RECRUITING

Trial details

NCT number: NCT06541860
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2023-08-21
Primary completion: 2028-02-21
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.